Veritable’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,556
Closed -$293K 956
2022
Q1
$293K Buy
1,556
+71
+5% +$13.5K ﹤0.01% 731
2021
Q4
$393K Sell
1,485
-26
-2% -$7K 0.01% 631
2021
Q3
$437K Sell
1,511
-84
-5% -$21.6K 0.01% 587
2021
Q2
$318K Sell
1,595
-110
-6% -$21.3K 0.01% 662
2021
Q1
$331K Sell
1,705
-83
-5% -$17K 0.01% 625
2020
Q4
$343K Buy
1,788
+198
+12% +$36K 0.01% 589
2020
Q3
$235K Buy
+1,590
New +$227K ﹤0.01% 647

Other funds holding RGEN

Veritable's RGEN Position: Q2 2022 in Review

Veritable sold out of Repligen (RGEN) in Q2 2022, closing a stake of 1,556 shares — an estimated $293K sold.

Veritable first reported a position in RGEN in Q3 2020 and held it in 7 quarters. The position peaked at $437K in Q3 2021. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Veritable reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • Veritable sold 1,556 Repligen shares in Q2 2022, an estimated $293K.
  • Veritable first reported a position in Repligen in Q3 2020 and held it in 7 quarters.
  • Veritable's Repligen position peaked at $437K in Q3 2021.
  • 404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Veritable's 13F filing for Q2 2022, filed 15 Aug 2022.